A Stang1,2, L Khil3, H Kajüter3, N Pandeya4, C D Schmults5, E S Ruiz5, P S Karia6, A C Green4,7. 1. Center of Clinical Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany. 2. Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA. 3. Cancer Registry of North Rhine-Westphalia, Bochum, Germany. 4. QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. 5. Population Health Department, Mohs and Dermatologic Surgery Center, Brigham and Women's Faulkner Hospital, Boston, MA, USA. 6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. CRUK Manchester Institute and Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Abstract
BACKGROUND: Population-based incidence and mortality studies of cutaneous squamous cell carcinoma (SCC) have been few owing to the commonness of the disease, and rare deaths making accurate mortality statistics difficult. OBJECTIVES: Our aim was to summarize SCC incidence and mortality in populations across three continents, exemplified by Australia, the United States (US) and Germany. METHODS: We estimated age-specific and age-standardized (Australian Standard 2001 Population) incidence and mortality rates per 100 000 person-years. RESULTS: Squamous cell carcinoma incidence is plateauing or falling in Australia, stable in the United States (2013-2015) and rising in Germany (2007-2015). Current incidence estimates in men and women are 341 and 209, 497 and 296, and 54 and 26, respectively, for the three countries. Incidence increases strongly with age in all countries. Mortality of non-melanoma skin cancer appears to be increasing in Germany and stable in Australia (unavailable for the US population). CONCLUSIONS: Squamous cell carcinoma is an important health issue, particularly among older men, with incidence exceeding most other cancers. More precise and uniform population-based studies of incidence and mortality are needed to better quantify the impact of SCC on healthcare systems worldwide and to gauge the effect of new treatments such as anti-PD1 therapy on mortality.
BACKGROUND: Population-based incidence and mortality studies of cutaneous squamous cell carcinoma (SCC) have been few owing to the commonness of the disease, and rare deaths making accurate mortality statistics difficult. OBJECTIVES: Our aim was to summarize SCC incidence and mortality in populations across three continents, exemplified by Australia, the United States (US) and Germany. METHODS: We estimated age-specific and age-standardized (Australian Standard 2001 Population) incidence and mortality rates per 100 000 person-years. RESULTS:Squamous cell carcinoma incidence is plateauing or falling in Australia, stable in the United States (2013-2015) and rising in Germany (2007-2015). Current incidence estimates in men and women are 341 and 209, 497 and 296, and 54 and 26, respectively, for the three countries. Incidence increases strongly with age in all countries. Mortality of non-melanoma skin cancer appears to be increasing in Germany and stable in Australia (unavailable for the US population). CONCLUSIONS:Squamous cell carcinoma is an important health issue, particularly among older men, with incidence exceeding most other cancers. More precise and uniform population-based studies of incidence and mortality are needed to better quantify the impact of SCC on healthcare systems worldwide and to gauge the effect of new treatments such as anti-PD1 therapy on mortality.
Authors: Peter D Baade; Danny R Youlden; Philippa Youl; Michael Kimlin; Craig Sinclair; Joanne Aitken Journal: Acta Derm Venereol Date: 2015-01 Impact factor: 4.437
Authors: Margaret P Staples; Mark Elwood; Robert C Burton; Jodie L Williams; Robin Marks; Graham G Giles Journal: Med J Aust Date: 2006-01-02 Impact factor: 7.738
Authors: Eckhard W Breitbart; Kohelia Choudhury; Markus P Anders; Beate Volkmer; Rüdiger Greinert; Alexander Katalinic; Jürgen Tacke; Ulrich Keilholz Journal: Oncol Res Treat Date: 2014-08-29 Impact factor: 2.825
Authors: Catherine M Olsen; Adèle C Green; Rachel E Neale; Penelope M Webb; Rebekah A Cicero; Lea M Jackman; Suzanne M O'Brien; Susan L Perry; Barbara A Ranieri; David C Whiteman Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196
Authors: Nora Eisemann; Annika Waldmann; Alan C Geller; Martin A Weinstock; Beate Volkmer; Ruediger Greinert; Eckhard W Breitbart; Alexander Katalinic Journal: J Invest Dermatol Date: 2013-07-22 Impact factor: 8.551
Authors: Bridie S Thompson; Catherine M Olsen; Padmini Subramaniam; Rachel E Neale; David C Whiteman Journal: Aust N Z J Public Health Date: 2015-11-11 Impact factor: 2.939
Authors: Christian Speckemeier; Kathrin Pahmeier; Pietro Trocchi; Katrin Schuldt; Hildegard Lax; Michael Nonnemacher; Patrik Dröge; Andreas Stang; Jürgen Wasem; Silke Neusser Journal: BMC Health Serv Res Date: 2022-06-11 Impact factor: 2.908
Authors: Timothy Budden; Caroline Gaudy-Marqueste; Sarah Craig; Yuan Hu; Charles H Earnshaw; Shilpa Gurung; Amelle Ra; Victoria Akhras; Patrick Shenjere; Ruth Green; Lynne Jamieson; John Lear; Luisa Motta; Carlos Caulín; Deemesh Oudit; Simon J Furney; Amaya Virós Journal: Clin Cancer Res Date: 2021-04-01 Impact factor: 13.801